Clinical Trial Update: A Study Comparing the Dulaglutide Pen and the Semaglutide Pen [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the dulaglutide pen with the semaglutide pen in adults with type 2 diabetes mellitus; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide pen (dulaglutide)
• Semaglutide pen (semaglutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2020-04-24